Funding for this research was provided by:
National Institutes of Health (1R01CA183904)
BRCA Foundation (NA)
Received: 19 October 2018
Accepted: 31 May 2019
First Online: 10 June 2019
Ethics approval and consent to participate
: Genomic DNA from 14 BRCA1/2-mutated tumors and their matched normal samples was sequenced in this study, as well as genomic DNA from 12 sporadic tumor samples. These samples were obtained as detailed in Telli et al. [CitationRef removed] This protocol was approved by the institutional review board at Stanford University. Informed consent was obtained from all patients.
: Not Applicable.
: All authors declare that they have no competing interests.